Arkolith/Insider Trading/CHRS/Form 4

Lanfear Dennis M

President & CEO, DirectorCoherus BioSciences, Inc. (CHRS) · full profile →Form 4 · filed Jun 8, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$421K
Net Open-Market Flow
-$421K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2021Sell(S)31K$13.56$421K493K
Jun 8, 2021Option exercise(M)31K$0.42$13K524K
Jun 6, 2021Option exercise(M)300K$0.42$126K493K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 8, 2021Option exercise(M)31K—$00
Jun 6, 2021Option exercise(M)300K—$031K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-21-011842) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML